Development Seed – Trademark Portfolio

Entity Type: 03

Development Seed holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ATRIUM, MAPBOX, and OPEN ATRIUM. The owner is based in Washington, DC.

1534 U Street NW Suite 2

Washington, DC 20009

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Development Seed's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (3 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Development Seed have?

Development Seed has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 cancelled.

What trademark classes does Development Seed file in?

Development Seed files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Development Seed's most well-known trademarks?

Development Seed's registered trademark portfolio includes well-known marks such as ATRIUM, MAPBOX, and OPEN ATRIUM. These are among 3 currently registered trademarks in the portfolio.

What is Development Seed's trademark registration success rate?

Development Seed has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.